XML 18 R7.htm IDEA: XBRL DOCUMENT v3.21.1
Consolidated Statements of Cash Flows - USD ($)
 12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Cash Flows from Operating Activities    
Net loss $ (17,036,837) $ (11,843,513)
Adjustments to reconcile net loss to net cash used in operating activities    
Depreciation and amortization expense 687,845 478,191
Bad debt expense 12,000 23,500
Impairment expense   3,113,020
Gain on forgiveness of debt (376,177)  
Equity based compensation expense 3,212,772 4,643,127
Recognized loss on marketable securities 22,416 160,449
Gain on sale of asset   (27,000)
Marketable securities distributed as compensation 3,917  
Expenses paid through financings 32,500 15,000
Loan principal paid directly through grant (8,853)
Amortization of debt discount and debt costs 1,840,745 39,372
Initial derivative expense 3,340,554
Change in derivative value due to anti-dilution adjustments 2,642,175
Change in fair value of derivative liability 2,658,261 (1,138,604)
Changes in operating assets and liabilities:    
Increase in accounts receivable (94,767) (58,804)
Increase in accounts receivable – related party (36,784) (4,340)
Increase in prepaid expenses and other current assets (68,542) (73,620)
Increase in accounts payable and accrued liabilities 626,895 2,752,033
Increase (decrease) in accounts payable and accrued liabilities – related parties (63,863) 507,425
Increase in other liabilities 173,525
Increase (decrease) in deferred revenue (93,937) 22,906
Net cash used in operating activities (2,526,155) (1,390,858)
Cash Flows from Investing Activities    
Proceeds from sale of marketable securities 17,009 68,702
Cash paid for customer contracts (50,000)
Proceeds from sale of asset   27,000
Cash paid for equipment (3,463)
Cash paid for software development (11,500)
Net cash provided (used) by investing activities (32,991) 80,739
Cash Flows from Financing Activities    
Proceeds from loans 398,545 45,005
Proceeds from convertible notes 2,476,000
Payments of notes (17,907) (105,034)
Advances on receivables 180,778
Repayments of advances on receivables (180,778)
Proceeds from sale of future revenues   424,510
Repayments of sale of future revenues (528,838) (27,259)
Deposit on purchase of preferred stock 500,000
Repayment of deposit on purchase of preferred stock (215,000)
Proceeds from sale of preferred stock 25,000 979,997
Net cash provided by financing activities 2,352,800 1,602,219
Net increase (decrease) in cash (206,346) 292,100
Cash, beginning of year 306,252 14,152
Cash, end of year 99,906 306,252
Supplemental disclosures of cash flow information:    
Cash paid during the year for interest 235,813 49,552
Cash paid during the year for income taxes
Supplemental schedule of non-cash investing and financing activities:    
Original issue discount deducted from convertible note proceeds 328,125
Debt costs deducted from convertible note proceeds 366,500
Preferred stock issued for accrued penalties 1,929,516
Notes and accrued interest converted to common stock 96,000  
Preferred stock issued for asset acquisition 8,600,000
Non-cash adjustments to Redeemable Preferred Stock of subsidiary 2,059,764
Notes payable and accrued interest exchanged for preferred stock 116,380
Noncontrolling interest reclassified to paid-in capital   1,591,221
Accounts payable paid through proceeds of preferred stock 100,000
Accrued compensation paid with common stock 56,250
Value of warrant issued with note 42,000
Accounts payable paid through proceeds of note 4,995
Warrant derivative liability at inception 5,625,519 1,750,646
Accrued compensation forgiven and credited to contributed capital 187,500
Discount attributable to liability on sale future revenues   142,491
Discount attributable to note payable   10,000
Marketable securities received as payment for Series D preferred stock 240,000
Notes and accrued interest forgiven $ 706,501